Interstitial Lung Diseases (ILD) are a group of chronic and progressive lung disorders that cause inflammation and scarring (fibrosis) of the lung tissues. These diseases affect the interstitium, the delicate tissue surrounding the air sacs of the lungs, making it difficult for oxygen to pass into the bloodstream. Over time, ILD can lead to breathing difficulties, reduced oxygen levels, chronic cough, fatigue, and permanent lung damage if not diagnosed and treated early.
Dr. Gurmeet Singh Chabbra, a highly experienced Pulmonologist and Sleep Medicine Specialist with more than 22 years of expertise, provides advanced diagnosis and comprehensive treatment for various Interstitial Lung Diseases. Having served at prestigious institutions like Marengo Asia Hospital, Fortis Escorts Hospital, Indraprastha Apollo Hospital, AIIMS Delhi, and LRS Institute of TB & Respiratory Diseases, Dr. Chabbra is recognized for his excellence in managing complex respiratory disorders using evidence-based and patient-focused care.
With extensive experience in advanced pulmonary procedures such as Bronchoscopy, EBUS-TBNA, Thoracoscopy, TBLB Biopsy, CT-guided procedures, and critical respiratory care, Dr. Chabbra offers personalized treatment plans aimed at improving breathing, slowing disease progression, and enhancing quality of life for ILD patients.
Interstitial Lung Diseases are a large group of lung disorders that mainly affect the interstitial tissues of the lungs. In ILD, the lung tissue becomes inflamed and scarred, causing stiffness in the lungs and difficulty in breathing. The scarring may gradually worsen and permanently reduce lung function if left untreated.
ILD can occur due to several causes, including:
Early detection is extremely important because many forms of ILD can progress silently before symptoms become severe.
Patients suffering from ILD may experience:
These symptoms often develop gradually, making timely consultation with a pulmonologist essential.
Dr. Gurmeet Singh Chabbra specializes in diagnosing and treating various forms of ILD, including:
A progressive lung disease characterized by severe scarring of lung tissues without a known cause.
Inflammation caused by repeated exposure to environmental allergens like bird proteins, mold, or dust.
An inflammatory disease that affects multiple organs, especially the lungs and lymph nodes.
Lung involvement due to autoimmune conditions such as Rheumatoid Arthritis, Lupus, or Scleroderma.
Lung fibrosis caused by prolonged exposure to silica dust, asbestos, coal dust, or industrial chemicals.
Lung damage resulting from certain medications or radiation therapy.
Several factors may increase the risk of developing Interstitial Lung Diseases, including:
Individuals working in factories, construction sites, mining industries, or environments with heavy dust exposure are at a higher risk.
Accurate diagnosis is crucial for proper management of ILD. Dr. Gurmeet Singh Chabbra uses advanced diagnostic techniques to identify the type and severity of lung disease.
Early and precise diagnosis helps initiate timely treatment and prevents irreversible lung damage.
Treatment for ILD depends on the type, severity, and progression of the disease. The primary goal is to reduce inflammation, slow fibrosis, improve breathing, and maintain lung function.
Special breathing exercises and rehabilitation programs help improve lung efficiency, stamina, and quality of life.
Patients with low oxygen levels may require oxygen support to improve breathing and prevent complications.
Dr. Chabbra is highly skilled in advanced procedures like:
Patients are advised regarding:
For severe or advanced ILD cases, specialized respiratory and critical care management may be required.
Without timely treatment, Interstitial Lung Diseases can lead to:
Early diagnosis and expert pulmonary care can significantly slow disease progression and improve long-term outcomes.
Over 22 years of expertise in Pulmonology, Sleep Medicine, and Critical Respiratory Care.
Specialized in Bronchoscopy, EBUS-TBNA, Thoracoscopy, TBLB Biopsy, and CT-guided procedures.
Worked with leading healthcare centers including:
Uses the latest medical advancements and internationally accepted treatment protocols.
Provides complete management for ILD, COPD, Asthma, Lung Cancer, Sleep Disorders, Pleural Diseases, and other respiratory conditions.
Focuses on personalized care, long-term disease management, and improving patients’ quality of life.
Although all ILDs cannot be prevented, certain precautions can reduce the risk:
Early symptoms usually include persistent dry cough, shortness of breath, fatigue, and reduced exercise tolerance.
Some forms of ILD can be managed effectively if diagnosed early. While scarring may not always be reversible, treatment can slow disease progression and improve symptoms.
Yes, smoking is a major risk factor for several types of Interstitial Lung Diseases and can worsen existing lung damage.
ILD is diagnosed using HRCT chest scans, pulmonary function tests, bronchoscopy, biopsies, blood tests, and clinical evaluation.
You should consult a pulmonologist if you experience persistent cough, unexplained breathlessness, chest discomfort, or prolonged respiratory symptoms.
Yes, advanced ILD can limit physical activity and breathing capacity, but timely treatment and pulmonary rehabilitation can significantly improve quality of life.
Some patients with low oxygen levels may require oxygen therapy to support breathing and improve overall health.
If untreated, ILD can cause severe lung fibrosis, respiratory failure, pulmonary hypertension, and other life-threatening complications.